Biosimilars

Graphic: Mint

Biocon suffers withdrawal symptoms

1 min read . 17 Aug 2017
While CCI ruled that Roche abused its dominant position to partially deny entry to other companies to produce and distribute trastuzumab it did not impose a penalty and ordered an investigation. Photo: Bloomberg

CCI orders probe against Roche

3 min read . 26 Apr 2017